Evidence map›Paper›PMID 41473427›Full record

ArticleFrontiers in oncology2025

Machine learning model for predicting neuropathic pain following thoracic oncology surgery.

Yu Zhang, Shirong Wu, Maolin Zhou, Hui Pan, Qing Fan, Jie Xie, Xue Xiao, Tian Zhang, Jinjun Shu, Yan Luo and 2 more

Abstract read
In one paragraph

Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Yu Zhang *Nursing Department,Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
Shirong Wu *Department of Medical oncology,Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
Maolin ZhouDepartment of Anesthesiology, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
Hui PanDepartment of Anesthesiology, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
Qing FanNursing Department,Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
Jie XieNursing Department,Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
Xue XiaoNursing Department,Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
Tian ZhangNursing Department,Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
Jinjun ShuDepartment of Anesthesiology, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
Yan LuoDepartment of Anesthesiology, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
Dongmei MaDepartment of Anesthesiology, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
Qing YangNursing Department,Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: Neuropathic pain (NP) is a common and challenging complication following thoracic oncology surgery, characterized by complex etiological factors. However, effective predictive models for identifying high-risk patients are currently lacking. This study aims to determine the incidence and key risk factors associated with neuropathic pain following thoracic oncology surgery, and to construct and validate a series of machine learning-based risk prediction models, providing a scientific foundation for clinical decision-making. Methods: This study involved 647 patients who underwent thoracic oncology surgery at a specialized cancer hospital in Sichuan Province, China (November 2022 to December 2023). An information survey was designed to collect general demographic data and influencing factors. Outcome indicators were assessed using the Numeric Rating Scale (NRS) for postoperative acute pain and the Douleur Neuropathique 4 Questionnaire (DN4) for neuropathic pain evaluation. Using stratified sampling, the patients were divided into training (80%) and testing (20%) datasets. Univariate analysis and LASSO regression were employed to identify independent risk factors for postoperative neuropathic pain, resulting in the selection of seven factors for model inclusion. Subsequently, six machine learning models were developed using Python 3.11: logistic regression (LR), K-nearest neighbors (K-NN), random forest (RF), support vector machine (SVM), XGBoost, and LightGBM (LGBM). To enhance model accuracy, parameter tuning and ten-fold cross-validation were employed, and performance was evaluated using the testing set with the Area Under the Curve (AUC) metric. A visualization analysis of the model's variable features was conducted, and the Shapley Additive Explanations (SHAP) values of the predictive models were calculated to identify the significant influencing factors and their respective impact levels on postoperative neuropathic pain in thoracic oncology. Results: The incidence of postoperative NP was 24.26%. The random forest model demonstrated the highest predictive performance (AUC = 0.86). SHAP value analysis revealed that the primary determinants for the onset of neuropathic pain include the surgical approach, the surgeon's expertise, the quantity of thoracic drainage tubes, the duration of thoracic drainage tube placement, postoperative acute pain, and C-reactive protein (CRP). Conclusions: The random forest model effectively predicts neuropathic pain following thoracic oncology surgery, facilitating early screening and targeted interventions to improve outcomes.

Indexed as

machine learningneuropathic painoncologypredictive modelsurgery, thoracic

Identifiers

PMID41473427
PMCPMC12745869

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.